Float Short %

8.47

Margin Of Safety %

Put/Call OI Ratio

0.63

EPS Next Q Diff

0.18

EPS Last/This Y

1.65

EPS This/Next Y

1.28

Price

57.34

Target Price

82.08

Analyst Recom

Performance Q

-0.62

Relative Volume

0.92

Beta

2.29

Ticker: RYTM

23 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-04-14	RYTM	60.13	0.58	20.42	7957
2025-04-15	RYTM	62.08	0.57	0.45	7957
2025-04-16	RYTM	61.39	0.58	2.17	7989
2025-04-17	RYTM	61.68	0.58	0.01	7990
2025-04-18	RYTM	61.74	0.58	0.01	7990
2025-04-21	RYTM	60.53	0.62	1.19	5261
2025-04-22	RYTM	59.21	0.62	0.03	5348
2025-04-23	RYTM	59.92	0.62	0.03	5371
2025-04-24	RYTM	63	0.61	0.01	5401
2025-04-25	RYTM	63.76	0.58382978723404	0.0044052863436123	5583
2025-04-28	RYTM	64.41	0.55156710420573	0.02043795620438	5792
2025-04-29	RYTM	65.16	0.54	0.11	5981
2025-04-30	RYTM	65.18	0.54	1.85	5989
2025-05-01	RYTM	63.32	0.54	0.17	6001
2025-05-02	RYTM	63.96	0.54	0.11	6024
2025-05-05	RYTM	64.4	0.54	0.09	6048
2025-05-06	RYTM	62.75	0.54	0.01	6046
2025-05-07	RYTM	64.47	0.54	0.20	6051
2025-05-08	RYTM	60.74	0.55	12.24	6025
2025-05-09	RYTM	57.36	0.60	6.89	6242
2025-05-12	RYTM	58.97	0.61	0.33	6284
2025-05-13	RYTM	56.76	0.61	1.46	6284
2025-05-14	RYTM	57.37	0.63	101.67	6358
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-04-14	RYTM	60.14	71.1	-	-2.53
2025-04-15	RYTM	62.09	71.1	-	-2.53
2025-04-16	RYTM	61.40	71.1	-	-2.53
2025-04-17	RYTM	61.74	71.1	-	-2.53
2025-04-18	RYTM	61.74	71.1	-	-2.53
2025-04-21	RYTM	60.55	71.1	-	-2.53
2025-04-22	RYTM	59.23	71.1	-	-2.53
2025-04-23	RYTM	59.84	71.1	-	-2.53
2025-04-24	RYTM	62.97	71.1	-	-2.53
2025-04-25	RYTM	63.76	71.1	-	-2.53
2025-04-28	RYTM	64.41	71.1	-	-2.53
2025-04-29	RYTM	65.22	71.1	-	-2.53
2025-04-30	RYTM	65.19	71.1	-	-2.53
2025-05-01	RYTM	63.80	71.1	-	-2.53
2025-05-02	RYTM	64.01	71.1	-	-2.53
2025-05-05	RYTM	64.41	71.1	-	-2.53
2025-05-06	RYTM	62.67	71.1	-	-2.53
2025-05-07	RYTM	64.63	71.1	-	-2.53
2025-05-08	RYTM	60.68	71.1	-	-2.53
2025-05-09	RYTM	57.38	-18.5	-	-2.69
2025-05-12	RYTM	58.97	-18.5	-	-2.69
2025-05-13	RYTM	56.79	-18.5	-	-2.69
2025-05-14	RYTM	57.34	-12.3	-	-2.69
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-04-14	RYTM	-3.75	-4.68	8.18
2025-04-15	RYTM	-3.76	-4.68	8.18
2025-04-16	RYTM	-3.76	-4.68	8.18
2025-04-17	RYTM	-3.76	-4.68	8.18
2025-04-18	RYTM	-3.76	-4.68	8.18
2025-04-21	RYTM	-3.76	-4.48	8.18
2025-04-22	RYTM	-3.76	-4.48	8.18
2025-04-23	RYTM	-3.76	-4.48	8.18
2025-04-24	RYTM	-3.75	-4.48	8.18
2025-04-25	RYTM	-3.73	-4.48	8.18
2025-04-28	RYTM	-3.73	-4.35	8.93
2025-04-29	RYTM	-3.73	-4.35	8.93
2025-04-30	RYTM	-3.73	-4.35	8.93
2025-05-01	RYTM	-3.83	-4.35	8.93
2025-05-02	RYTM	-3.93	-4.35	8.93
2025-05-05	RYTM	-3.93	-5.32	8.93
2025-05-06	RYTM	-3.93	-5.32	8.93
2025-05-07	RYTM	-3.93	-5.32	8.93
2025-05-08	RYTM	-3.93	-5.32	8.93
2025-05-09	RYTM	-3.79	-5.32	8.92
2025-05-12	RYTM	-3.79	-1.02	8.47
2025-05-13	RYTM	-3.79	-1.02	8.47
2025-05-14	RYTM	-2.61	-1.02	8.47
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

-0.81

Avg. EPS Est. Current Quarter

-0.65

Avg. EPS Est. Next Quarter

-0.63

Insider Transactions

-2.61

Institutional Transactions

-1.02

Beta

2.29

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

16.4

Max Drawdown 5-Year %

-92.1

Target Price

82.08

P/E

Forward P/E

PEG

P/S

26.63

P/B

191.96

P/Free Cash Flow

EPS

-2.82

Average EPS Est. Cur. Y

-2.69

EPS Next Y. (Est.)

-1.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-127.12

Relative Volume

0.92

Return on Equity vs Sector %

-130.4

Return on Equity vs Industry %

-113.5

EPS 1 7Days Diff

-0.2

EPS 1 30Days Diff

-0.16

EBIT Estimation

Rhythm Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 283

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.

stock quote shares RYTM – Rhythm Pharmaceuticals Inc. Stock Price stock today

news today RYTM – Rhythm Pharmaceuticals Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch RYTM – Rhythm Pharmaceuticals Inc. yahoo finance google finance

stock history RYTM – Rhythm Pharmaceuticals Inc. invest stock market

stock prices RYTM premarket after hours

ticker RYTM fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: RYTM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y